Pierre Legault
CIK 1391045 · Chief Executive Officer · last filed 2026-02-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.27M
Companies
12
Total Filings
61
Lifetime Open-Market Net
-$12.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SNDX | Director | 114,000 | $18.25 | $2.08M | -$2.55M | 15 | 2026-02-06 |
| BCYC | Director | 46,000 | $4.05 | $186.3K | -$10.04M | 14 | 2025-01-06 |
| Urovant Sciences Ltd. (UROV) Delisted | Director | 21,480 | $16.24 | $348.8K | $0 | 4 | 2020-07-23 |
| ARMO BioSciences, Inc. (ARMO) Delisted | Director | — | — | — | $0 | 2 | 2018-06-22 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Director | — | — | — | $0 | 3 | 2016-01-14 |
| NephroGenex, Inc. (NRX) Delisted | Chief Executive Officer | 659,430 | — | — | $0 | 3 | 2015-11-12 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | Director | — | — | — | $0 | 3 | 2015-02-24 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | Director | — | — | — | $0 | 1 | 2014-01-03 |
| Forest Laboratories, LLC (FRX) Delisted | Director | 1,761 | $12.00 | $21.1K | $0 | 2 | 2013-08-16 |
| OSI PHARMACEUTICALS INC (OSIP) Delisted | Exec. VP, CFO & Treasurer | 20,375 | — | — | $0 | 4 | 2010-06-07 |
| RITE AID CORP (RAD) Delisted | Senior Executive VP | 206,505 | $0.65 | $133.9K | $0 | 5 | 2008-06-27 |
| Bio Green Med Solution, Inc. (CYCCP) Delisted | Director | — | $5.05 | — | $0 | 2 | 2008-02-21 |
Recent Filings · Page 5 of 7
61 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-05-04 | NephroGenex, Inc. (NRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-02-24 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Disp (D) | — | $0 | EDGAR |
| 2015-02-20 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-05 | Tobira Therapeutics, Inc. (TBRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-15 | NephroGenex, Inc. (NRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-11-05 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-07-03 | — | Disp (D) | −1,761 | $0 | |
| 2014-01-03 | Tobira Therapeutics, Inc. (RGDO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-08-16 | Forest Laboratories, LLC (FRX) Delisted | Grant (A) | +1,761 | $0 | EDGAR |
| 2012-08-27 | Forest Laboratories, LLC (FRX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.